The authors explore the relationship between mutations in genes causing clonal hematopoiesis of indeterminate potential (CHIP) and atherothrombotic disorders, along with potential mechanisms of enhanced clonal outgrowth and potential therapies and strategies to slow CHIP progression.
[Thrombosis and Haemostasis]
